Zelluna ASA - Proxy Solicitation & Information Statement 2020

Ultimovacs ASA: Notice of Extraordinary General Meeting on 11 November 2020 - proposed changes to the Board of Directors

Oslo, 21 October 2020: The Board of Directors hereby calls for the Extraordinary General Meeting of Ultimovacs ASA in the meeting room ‘Jónas Einarsson’s auditorium’ in Ullernchausséen 64, 0379 Oslo, at 15:00 CET on 11 November 2020.

Board member Kristin Wilhelmsen has asked to be replaced on the Company's Board. The Company's Nomination Committee has issued a statement with a proposal for changes to the composition of the Company's Board, where it is proposed that Aitana Peire and Haakon Stenrød are elected as new board members.

All documents regarding the Extraordinary General Meeting are available at the Company’s website: www.ultimovacs.com/investors/governance

Due to the extraordinary situation with the corona virus Covid-19, and in light of the travel and meeting recommendations and restrictions currently in place, the Board has found it necessary to urge shareholders to vote through submission of proxy forms prior to the meeting and not attend the meeting in person.

For further information, please visit www.ultimovacs.com or contact:

Jónas Einarsson, Chairman of the Board of Directors of Ultimovacs ASA

Email: [email protected]

Phone: +47 480 96 355

Carlos de Sousa, CEO

Email: [email protected]

Phone: +47 908 92507

Hans Vassgård Eid, CFO

Email: [email protected]

Phone: +47 482 48632